International Journal of Nanomedicine · 2024 · 19 citations · 28 references
Natural SciencesBioengineeringBiomedical EngineeringBiocompatibilityBiomaterialsDrug DeliveryAntimicrobial BiomaterialsCollagen-based BiomaterialsDrug Delivery BiomaterialsDrug EncapsulationGelsHydrogelsBiofilm DevelopmentCollagen-chitosan CompositesEncapsulation EfficiencyHydrogel CompositesHydrogel Drug Delivery SystemsHydrogel-based DeliveryHydrogel-based SystemsSustained-release Systems
Purpose: Surgical site infections pose a significant challenge for medical services. Systemic antibiotics may be insufficient in preventing bacterial biofilm development. With the local administration of antibiotics, it is easier to minimize possible complications, achieve drugs' higher concentration at the injured site, as well as provide their more sustained release. Therefore, the main objective of the proposed herein studies was the fabrication and characterization of innovative hydrogel-based composites for local vancomycin (VAN) therapy. Methods: Presented systems are composed of ionically gelled chitosan particles loaded with vancomycin, embedded into biomimetic collagen/chitosan/hyaluronic acid-based hydrogels crosslinked with genipin and freeze-dried to serve in a flake/disc-like form. VAN-loaded carriers were characterized for their size, stability, and encapsulation efficiency (EE) using dynamic light scattering technique, zeta potential measurements, and UV-Vis spectroscopy, respectively. The synthesized composites were tested in terms of their physicochemical and biological features. Results: was established. Moreover, in vitro cell culture study revealed that the surfaces of all prepared systems are biocompatible as they supported the proliferation and adhesion of the model MG-63 cells. In addition, we have demonstrated significantly prolonged VAN release while minimizing the initial burst effect for the composites compared to bare nanoparticles and verified their desired physicochemical features during swellability, and degradation experiments. Conclusion: It is expected that the developed herein system will enable direct delivery of the antibiotic at an exposed to infections surgical site, providing drugs sustained release and thus will reduce the risk of systemic toxicity. This strategy would both inhibit biofilm formation and accelerate the healing process.
28
Janitha M. Unagolla, Ambalangodage C. Jayasuriya · European Journal of Pharmaceutical Sciences · 2017 · 401 citations
The use of vancomycin with its therapeutic and adverse effects: a review.
Felipe Ribeiro Bruniera, Felipe Ferreira, L R M Saviolli et al. · PubMed · 2015 · 277 citations · Full text
Negar Hassani Besheli, Fatemeh Mottaghitalab, Masoud Eslami et al. · ACS Applied Materials & Interfaces · 2017 · 176 citations
Erdal Cevher, Zafer Orhan, Demet Şensoy et al. · International Journal of Pharmaceutics · 2006 · 151 citations